111 related articles for article (PubMed ID: 37741096)
1. YAP/TEAD-induced PRIM1 contributes to the progression and poor prognosis of gastric carcinoma.
Guo Z; Guo L
Transl Oncol; 2023 Dec; 38():101791. PubMed ID: 37741096
[TBL] [Abstract][Full Text] [Related]
2. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
3. DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination.
Zhu M; Wu M; Bian S; Song Q; Xiao M; Huang H; You L; Zhang J; Zhang J; Cheng C; Ni W; Zheng W
Cell Biosci; 2021 Feb; 11(1):42. PubMed ID: 33622397
[TBL] [Abstract][Full Text] [Related]
4. The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1).
He S; Zhang H; Xiao Z; Bhushan S; Gao K; Wang W
Bioengineered; 2021 Dec; 12(1):601-614. PubMed ID: 33517828
[TBL] [Abstract][Full Text] [Related]
5. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
[TBL] [Abstract][Full Text] [Related]
6. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
[TBL] [Abstract][Full Text] [Related]
7. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
9. Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer.
Kim SH; Jin H; Meng RY; Kim DY; Liu YC; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547587
[TBL] [Abstract][Full Text] [Related]
10. PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer.
Liu Y; Lu Y; Xing Y; Zhu W; Liu D; Ma X; Wang Y; Jia Y
Mol Carcinog; 2024 May; ():. PubMed ID: 38804704
[TBL] [Abstract][Full Text] [Related]
11. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.
Wang Y; Chen H; Liu W; Yan H; Zhang Y; Cheung AHK; Zhang J; Chen B; Liang L; Zhou Z; Wong CC; Wu WKK; Chan MWY; Cheng ASL; Ma BBY; Yu J; Lo KW; To KF; Kang W
Theranostics; 2022; 12(15):6509-6526. PubMed ID: 36185598
[No Abstract] [Full Text] [Related]
12. PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression.
Song S; Wang Z; Li Y; Ma L; Jin J; Scott AW; Xu Y; Estrella JS; Song Y; Liu B; Johnson RL; Ajani JA
Mol Cancer Res; 2020 Mar; 18(3):390-402. PubMed ID: 31796534
[TBL] [Abstract][Full Text] [Related]
13. DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpoint.
Lee WH; Chen LC; Lee CJ; Huang CC; Ho YS; Yang PS; Ho CT; Chang HL; Lin IH; Chang HW; Liu YR; Wu CH; Tu SH
Int J Cancer; 2019 Feb; 144(3):615-630. PubMed ID: 30097999
[TBL] [Abstract][Full Text] [Related]
14. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer analysis, cell and animal experiments revealing TEAD4 as a tumor promoter in ccRCC.
Li F; Feng Y; Jiang Q; Zhang J; Wu F; Li Q; Jing X; Wang X; Huang C
Life Sci; 2022 Mar; 293():120327. PubMed ID: 35065165
[TBL] [Abstract][Full Text] [Related]
16. USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancer.
Liu Z; Li J; Ding Y; Ma M; Chen J; Lei W; Li L; Yao Y; Yu X; Zhong M; Liao Q; Fang W; Fan L; Huang C; Zhong H; Wen Q; Fang Z; Chen J; Huang S; Xiong J; Xiang X; Deng J
Oncogene; 2022 Apr; 41(18):2555-2570. PubMed ID: 35318441
[TBL] [Abstract][Full Text] [Related]
17. Myosin light chain 9 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells by binding to Yes-associated protein 1 and regulating Hippo signaling.
Feng M; Dong N; Zhou X; Ma L; Xiang R
Bioengineered; 2022 Jan; 13(1):96-106. PubMed ID: 34974798
[TBL] [Abstract][Full Text] [Related]
18. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice.
Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA
Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333
[TBL] [Abstract][Full Text] [Related]
19. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Hedgehog-Smoothened Signaling Depends on YAP1‒TAZ/TEAD Transcription to Restrain Differentiation in Basal Cell Carcinoma.
Yuan Y; Salinas Parra N; Chen Q; Iglesias-Bartolome R
J Invest Dermatol; 2022 Jan; 142(1):65-76.e7. PubMed ID: 34293352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
